U.S. flag

An official website of the United States government

NM_001070.5(TUBG1):c.1022G>A (p.Arg341Gln) AND Complex cortical dysplasia with other brain malformations 4

Germline classification:
Pathogenic/Likely pathogenic (3 submissions)
Last evaluated:
Jan 3, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001809474.5

Allele description [Variation Report for NM_001070.5(TUBG1):c.1022G>A (p.Arg341Gln)]

NM_001070.5(TUBG1):c.1022G>A (p.Arg341Gln)

Gene:
TUBG1:tubulin gamma 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q21.2
Genomic location:
Preferred name:
NM_001070.5(TUBG1):c.1022G>A (p.Arg341Gln)
HGVS:
  • NC_000017.11:g.42614521G>A
  • NG_033886.1:g.10182G>A
  • NM_001070.5:c.1022G>AMANE SELECT
  • NP_001061.2:p.Arg341Gln
  • NC_000017.10:g.40766539G>A
  • NM_001070.4:c.1022G>A
Protein change:
R341Q
Links:
dbSNP: rs1555631467
NCBI 1000 Genomes Browser:
rs1555631467
Molecular consequence:
  • NM_001070.5:c.1022G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Complex cortical dysplasia with other brain malformations 4
Identifiers:
MONDO: MONDO:0014171; MedGen: C3809420; OMIM: 615412

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV0020588113billion
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jan 3, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002543794Suma Genomics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenicde novoclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV005042675Neuberg Centre For Genomic Medicine, NCGM
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenicgermlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedde novoyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyes1not providednot provided1not providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From 3billion, SCV002058811.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

Same nucleotide change resulting in same amino acid change has been previously reported to be associated with TUBG1 related disorder (ClinVar ID: VCV000452987, PS1_P). The variant was observed to be de novo (3billion dataset, PS2_S). A different missense change at the same codon has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000373145, PM5_M). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.795, 3CNET: 0.963, PP3_P). A missense variant is a common mechanism associated with Cortical dysplasia (PP2_P). It is not observed in the gnomAD v2.1.1 dataset (PM2_M).Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided

From Suma Genomics, SCV002543794.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyesnot providednot providednot providednot providednot providednot providednot provided

From Neuberg Centre For Genomic Medicine, NCGM, SCV005042675.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The missense variant c.1022G>Ap.Arg341Gln in TUBG1 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. A different missense change c.1021C>Tp.Arg341Trp at the same codon has been reported as Pathogenic/Likely Pathogenic Yuen YTK, et al., 2019.The variant is novel not in any individuals in gnomAD Exomes and 1000 Genomes. This variant has been reported to the ClinVar database as Pathogenic. However, study on multiple affected individuals and functional impact of the variant is not available.The amino acid Arginine at position 341 is changed to a Glutamine changing protein sequence and it might alter its composition and physico-chemical properties. The amino acid change p.Arg341Gln in TUBG1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024